Objective: To investigate the possible influence of single-dose 2.0 g azithromycin (AZ-ER) on anticoagulation in patients taking warfarin.
Introduction
Warfarin is the most commonly-prescribed oral anticoagulant and is used in the management of thromboembolic diseases 1) . Various antibiotics have been reported to interact with warfarin. In daily practice, the dentist usually uses antibiotics either as prophylactic cover or in the therapeutic management of infection. Antibiotics used in dentistry also have a possible capacity to interact with warfarin, producing a clinically-significant alteration in anticoagulation status [1] [2] [3] .
A novel microsphere-based azithromycin extended-release formulation (AZ-ER) allows administration of a high oral dose of azithromycin as single dose regimen, while maintaining tolerability 4, 5) . Azithromycin is known as an effective antibiotic in the treatment of odontogenic infections, 6) and the administration of a single large dose of azithromycin as front-loading achieves more rapid bacterial eradication and prophylaxis of postoperative infections including prevention of infective endocarditis 7, 8) .
Azithromycin is an azalide, a subclass of macrolide antibiotics 9) . Some case reports have suggested that macrolides have the potential to enhance the anticoagulation effect of warfarin [1] [2] [3] . However, no prospective study has yet evaluated the effect of AZ-ER on the anticoagulation of warfarin therapy.
The purpose of this study was to investigate the possible influence of AZ-ER on anticoagulation in patients taking warfarin.
Materials and Methods
This study included a total of 18 consecutive patients receiving long-term stable warfarin therapy with an International Normalized Ratio (INR) of less than 3.0 and who required a dental extraction. Patients who had an allergic reaction for azithromycin, who had any other hemorrhagic diathesis, or who had received treatment with any systemic antibiotic within the previous 7 days were excluded from the study.
AZ-ER (a single 2.0-g dose of azithromycin) was administered orally on an empty stomach and more than 1-hour prior to the tooth extraction. Dental extractions were performed under local anesthesia using 2% (20 mg/ml) lignocaine hydrochloride with 1/80,000 (12.5µg/ml) adrenaline. Dental extractions were conducted using forceps and The azithromycin concentration of dental alveolar blood in extraction wounds as well as in peripheral venous blood at the same time was assessed by modified Shepard's high-performance liquid chromatography (HPLC). Immediately after each tooth extraction, blood from extraction wounds was collected directly into a sterile syringe while avoiding contamination with saliva by using dental cotton rolls.
The INR value was measured using the CoaguChek XS® system (Roche Diagnostics, Indianapolis) prior to AZ-ER administration, during, one-day after, and seven-days after the tooth extraction using capillary blood from a fingertip or untreated venous whole blood.
This study was approved by the institutional review board and all participants gave written informed consent.
Results
A total of 18 patients (13 men and 5 women, with a median age of 72.5 years) were available for the study. The patient data are summarized in Table 1 . The time period between AZ-ERM administration and extraction varied between 60 to 120 minutes.
Tooth extractions were carried out by trained oral surgeons and no remarkable troubles were noted. Five patients did not request a pain-killer and 9 patients took a single dose of loxoprofen, 1 patient two doses, 2 patients three doses, and 1 patient six doses. All analgesics were taken on the day of and the day after the extraction. No additional pain-killers were administered on or after the third day from extraction.
The azithromycin concentration distributions are shown in Figure 1 . The concentration in extraction wounds varied from 0.16 µg/ml to 4.34 µg/ml with a median concentration of 0.85 µg/ml, while the concentration in venous blood varied from 0.05 µg/ml to 2.13 µg/ml with a median concentration of 0.54 µg/ml. Linear approximation showed a gentle increase of azithromycin concentrations during the period between 60
and 120 minutes after AZ-ER administration, and the concentration level in extraction sites was higher than that in the peripheral veins. The relationship between change of INR value (difference between pre-administration and 7 days after extraction) and dose of analgesics is shown in Immediate postoperative bleeding was observed in one patient and the bleeding was easily stopped with an additional suture and direct pressure. Neither delayed bleeding, infection, nor adverse effects related to AZ-ER were observed through the study.
Discussion
To date, various antibiotics have been used in dental pratice 8) . In this study, we used single-dose 2.0 g azithromycin, which is a persistent extended-release formulation 5) .
The safety of massive doses of azithromycin is confirmed, and a single-dose of 2.0g of azithromycin can yield a high blood concentration 4, 5) . AZ-ER is thought to show high penetration into inflammation tissue 4-6, 9, 10) . We therefore measured the azithromycin concentration in tooth extraction sites and compared with that in venous blood during a period between 60 and 120 minutes after AZ-ER administration. The results of this study showed that the concentration level in extraction sites was higher than that in the peripheral veins. Lai et al. measured steady-state levels of azithromycin in gingival crevicular fluid (GCF) and reported that the concentrations in GCF were higher and more sustained than those in serum. They suggested that the pharmacokinetic profiles of azithromycin are different in GCF and serum 6) . It was also reported that azithromycin attenuates acute and chronic tissue inflammation 4, 5, 9, 10) . A higher concentration of azithromycin into the tooth extraction site is considered beneficial for preventing infection after tooth extraction.
We found no significant interaction between oral intake of AZ-ER and warfarin. . Several studies have shown that CYP expression and activity may be decreased in humans during infection or inflammation, resulting in lowered drug clearance, increased toxicity and altered physiological function 1, 2) . The infection itself (inflammatory syndrome) may alter the warfarin metabolism or hepatic clotting factor synthesis 2, 3) . Nonsteroidal anti-inflammatory drugs (NSAIDs) are known to interact with the oral anticoagulant warfarin and can cause serious bleeding complications 11, 12) , although the results of this study failed to show significant relationship between the dose of NSAIDs and INR value.
In the current study, prophylactic administration of a single-dose 2.0 g azithromycin to patients receiving daily warfarin therapy and having a stable coagulation status had no relevant effect on the anticoagulant effect of warfarin. However, in general, responses to warfarin therapy can be unpredictable, and we should continue to take into account the rare and sometimes serious sequelae. 
